Our core is SIGMOLECS, a proprietary technology combining peptides with hyaluronic acid, acting directly at the site of application. Our portfolio includes medical devices for orthopaedics, sports medicine, rheumatology, pain therapy and rehabilitation, and solutions for aesthetic medicine offering quick post-procedure recovery and long-term optimization of skin’s regenerative capacity. All products for medical promotion are made in EU/Swiss facilities and positioned in the premium segment under strict quality standards.
Contrad Swiss SA

Based in Switzerland, our company pioneers the development of cutting-edge substance-based products within the field of regenerative medicine.
Contrad Swiss is a life sciences company advancing non-invasive solutions in musculoskeletal and aesthetic regenerative medicine.
Activities
Main Activity
Licensing-Out
Trading
Drug development
Drug commercialization
Therapeutic Areas
Orthopedics
Pain
Other therapeutic areas
Markets
LATAM
MENA
ASEAN
Drug Stages
Market
Drug Product Forms
Topical
Certifications
Swissmedic
GMP
ISO 9001
ISO 13485
AIFA